Tusamitamab ravtansine

Synonyms: SAR-408701

For research use only. Not for use in humans.

Home Biosimilar Antibodies Others Antibody-Drug Conjugate inhibitor Tusamitamab ravtansine

Tusamitamab Ravtansine (SAR-408701), is an antibody-drug conjugate (ADC) composed of CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule ) targeting antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. TUSAMITAMAB RAVTANSINE has the potential for use in research of several solid tumors.

Tusamitamab ravtansine

CAS No. 2254086-60-5

Purity & Quality Control

Batch: D402601 Purity: 99% Protein concentration: 5.75mg/ml Endotoxin Level: ＜1EU/mg
99

Tusamitamab ravtansine Specificity

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Tusamitamab Ravtansine (SAR-408701), is an antibody-drug conjugate (ADC) composed of CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule ) targeting antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. TUSAMITAMAB RAVTANSINE has the potential for use in research of several solid tumors.
  • https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.9039

Product Details

CAS No. 2254086-60-5
ADC antiody Tusamitamab
ADC cytotoxin DM4
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.